- €2.24bn
- €9.78bn
- €4.61bn
- 40
- 82
- 94
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,169 | 4,548 | 4,675 | 4,977 | 4,609 |
Cost of Revenue | |||||
Gross Profit | 1,722 | 2,791 | 1,954 | 3,311 | 2,196 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,728 | 4,081 | 3,945 | 3,703 | 3,359 |
Operating Profit | 441 | 467 | 731 | 1,274 | 1,251 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -184 | 236 | 33.7 | 495 | 469 |
Provision for Income Taxes | |||||
Net Income After Taxes | -273 | 111 | -102 | 334 | 39.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -298 | 35.7 | -189 | 111 | 153 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -298 | 35.7 | -189 | 111 | 153 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.444 | -0.014 | -0.318 | 0.142 | -0.264 |